AzTrials
AzTrials

Nicotine Dependence Tobacco ProductNCT03276767

Comparing SMS and E-mail Reminders in an Online Smoking Cessation Intervention

A study testing Endre in people with Nicotine Dependence Tobacco Product, run by University of Oslo at 2 sites in 2 countries.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The primary purpose of the current study is to compare the effect of SMS-textmessage vs e-mail reminders on user engagement and proportion of reported quit attempts in an online smoking cessation intervention. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Nicotine Dependence Tobacco Product
What is being tested?
Endre
Could I receive a placebo?
No, everyone receives an active treatment
How many people
700 participants
Where
2 sitesin 2 countries
Study dates
12 Sep 2017to 1 Oct 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • 18 years or older
  • current smoker
  • determined to or considering to quit smoking
  • provide valid e-mail address
  • provide valid norwegian cell phone number
  • complete a baseline questionnaire
  • start using the intervention (pushing the next page button one time or more on the first session provided)
  • has not logged on to any of the online session within noon on the second day after that particular session was made available

Who cannot join

  • Not starting the first treatment session
  • Taking every treatment session on time (no need for reminders, and thus not randomized)

Trial locations and contacts

2 sites in 2 countries.

Håvar Brendryen, PhD contact

99521714 ext. +47

brendryen@gmail.com

2 sites in 2 countries

Czechia1 site, 1 recruiting
  • Department of Addictology, 1st Faculty of Medicine, Charles University

    Prague

    Roman Gabrhelík, PhD, gabrhelik@adiktologie.cz

    Not yet recruiting

Other trials in Czechia

Norway1 site, 1 recruiting
  • The Norwegian Centre for Addiction Research

    Oslo

    Håvar Brendryen, PhD, 99521714 ext. +47, brendryen@gmail.com

    Recruiting

Other trials in Norway

About this study

Official title: An RCT Comparing Reminders Sendt by SMS or by E-mail in an Online Smoking Cessation Intervention

The primary purpose of the current study is to compare the effect of SMS-textmessage vs e-mail reminders on user engagement and proportion of reported quit attempts in an online smoking cessation intervention.

Read the detailed description

Web- and mobile phone health behavior change interventions, including smoking cessation programs, offer great promise, but little is known about how such interventions should be designed to increase user engagement. The primary purpose of the current study is to compare the effect of SMS-textmessage vs e-mail reminders on user engagement and proportion of reported quit attempts in an online smoking cessation intervention.

The investigators propose a 2-arm RCT with 700 adult study participants that all receive a best practices web-based smoking cessation program designed for use on smart phones (web-app). The intervention includes a ten day preparation phase, in which participants continue smoking. On the eleventh day (and onward) the user will receive a session in which (s)he is asked whether (s)he has quit smoking or not. If not, the user will receive additional treatment sessions until (s)he reports having quit (or dropped out of the study). Each day (for up to 14 days) a new unique session is assigned to the user. However, if the user does not log on to the web-intervention and starts using the session by noon on the second day after assignment, the user will receive a reminder to do so. When a user is to be sent a reminder for the first time, (s)he will be randomized to either receive such reminders by SMS or by e-mail.

The primary outcome is reporting a quit attempt or not. Secondary outcomes include number web-sessions started and completed and time spent navigating sessions after the first reminder is received.

Being tested
Endre
Keywords
online intervention, e-Health, reminder, SMS-textmessage, e-mail, mobile phone, cell phone
Medical subject headings
Tobacco Use Disorder

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • EndreOther

    The online intervention, "Endre", a digital smoking cessation counsellor that communicates with the user primarily through interactive web-sessions. Intervention content is tailored based on user input and individual usage pattern. Up to 14 unique sessions is assigned to the users during the study period, one each day. If a user does not start a session by noon on the second day a reminder will be sendt.

Study groups in NCT03276767
Study groupRoleWhat they receive
Online intervention with SMS reminderExperimentalReminders will be sendt by SMS-TEXTMESSAGE if users of "Endre" does not log on to an assigned online session by noon on the second day.
Receives: Other: Endre
Online intervention with e-mail reminderActive comparatorReminder will be sendt by E-MAIL if users of "Endre" does not log on to an assigned online session by noon on the second day.
Receives: Other: Endre

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Quit attempt

    User report a quit attempt

    Measured: Within 6 weeks after starting the first session of the intervention

Secondary outcomes (2)
  1. Number of sessions completed

    Counted from after first reminder until reported quitting or study dropout (a unique session is made available each day)

    Measured: Within 6 weeks after starting the first session of the intervention

  2. Number of sessions started after first reminder

    Counted from after first reminder until reported quitting or study dropout (a unique session is made available each day)

    Measured: Within 6 weeks after starting the first session of the intervention

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted8 Sep 2017
  2. Study start12 Sep 2017
  3. Primary completion1 Oct 2022 (estimated)
  4. Study completion1 Oct 2022 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Model description
Participants receive one out of two versions of a web-based smoking cessation program. The only difference between the two versions is the medium of the reminder: either SMS-textmessage or e-mail.
Masking
None (open label)
Enrolment
700 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03276767
Sponsor's protocol ID
NFR 228158/H10-C
Status last verified
Sep 2021
First submitted
7 Sep 2017
Last updated
8 Oct 2021
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Holter MT, Johansen A, Brendryen H. How a Fully Automated eHealth Program Simulates Three Therapeutic Processes: A Case Study. J Med Internet Res. 2016 Jun 28;18(6):e176. doi: 10.2196/jmir.5415.

    PubMed 27354373
  • Kulhanek A, Lukavska K, Gabrhelik R, Novak D, Burda V, Prokop J, Holter MTS, Brendryen H. Comparing Reminders Sent via SMS Text Messaging and Email for Improving Adherence to an Electronic Health Program: Randomized Controlled Trial. JMIR Mhealth Uhealth. 2022 Mar 18;10(3):e31040. doi: 10.2196/31040.

    PubMed 35302945

Questions about this trial

What is this clinical trial studying?

A study testing Endre in people with Nicotine Dependence Tobacco Product, run by University of Oslo at 2 sites in 2 countries.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 8 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 8 Oct 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in Czechia, Norway. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Håvar Brendryen, PhD (99521714 ext. +47, brendryen@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Quit attempt (time frame: Within 6 weeks after starting the first session of the intervention). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03276767, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Oct 2021.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in